Finland· FI-REL-REL63336
Roclanda
A latanoprost and netarsudil product containing latanoprost + netarsudil mesylate, registered in Finland by Paranova Oy. The same ATC class is registered in 14 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Latanoprost and netarsudil is registered in 14 of 19 countries.
Countries holding a registration under ATC S01EE51 (latanoprost and netarsudil), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 10 of them publish a price we can compare per daily dose
Latanoprost and netarsudil · ATC S01EE51
14 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Fimea (Finland)- Active substance
- Latanoprost + Netarsudil mesylate
- Manufacturer
- Paranova Oy
- Country
- Finland (FI)
- ATC code
- S01EE51
- ATC class
- Latanoprost and netarsudil
- Defined daily dose
- 0.1 ml, AT
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 1
1 priced- fi_myyntilupa0426723 x 2.5 mlEUR 47.69
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Latanoprost and netarsudil in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaROCLANDASanten OY, Tampere
- SpainROCLANDA 50 MICROGRAMOS/ML + 200 MICROGRAMOS/ML COLIRIO EN SOLUCIONSanten Oy
- SwitzerlandRoclanda, collyre en solutionSanten SA
- United KingdomRoclanda 50micrograms/ml + 200micrograms/ml eye dropsSanten UK Ltd
- NorwayRoclandaAbacus Medicine A/S
- United StatesRocklatanAlcon Laboratories, Inc.
- IrelandRoclanda 50 micrograms/ml + 200 micrograms/ml eye drops, solutionSanten OY
- IcelandRoclandaSanten Oy*
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Roclanda
- Liechtenstein · Roclanda
- Norway · Roclanda
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f5c690ad-211e-4841-8320-43451c069fe1 GET /v1/drugs/f5c690ad-211e-4841-8320-43451c069fe1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "0.1",
"form": "silmätipat, liuos",
"route": "Silmän pinnalle",
"ddd_unit": "ml",
"strength": "50 mikrog/ml + 200 mikrog/ml",
"atc_label": "latanoprosti ja netarsudiili",
"ma_number": null,
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": "EU/1/20/1502/002",
"fimea_rel_id": "REL63336",
"authorised_at": "2024-10-03"
}See everything about latanoprost and netarsudil.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.